1 | imm cosponsored the first | | | | | | 2 | 0.53% |
2 | national academy of sciences | | | | | | | 2 | 0.53% |
3 | skip to primary navigation | | | | | | | 1 | 0.27% |
4 | portfolio” imm cosponsored the | | | | | | 1 | 0.27% |
5 | the emerging field of | | | | | | | 1 | 0.27% |
6 | in the emerging field | | | | | | | 1 | 0.27% |
7 | textbooks in the emerging | | | | | | | 1 | 0.27% |
8 | the first three 3 | | | | | | | 1 | 0.27% |
9 | cosponsored the first three | | | | | | 1 | 0.27% |
10 | rd portfolio” imm cosponsored | | | | | | 1 | 0.27% |
11 | field of nanotechnology applied | | | | | | | 1 | 0.27% |
12 | initiative’s rd portfolio” imm | | | | | | | 1 | 0.27% |
13 | “balancing the national nanotechnology | | | | | | | 1 | 0.27% |
14 | paper “balancing the national | | | | | | | 1 | 0.27% |
15 | white paper “balancing the | | | | | | | 1 | 0.27% |
16 | 2002 white paper “balancing | | | | | | | 1 | 0.27% |
17 | and technology policy a | | | | | | | 1 | 0.27% |
18 | science and technology policy | | | | | | | 1 | 0.27% |
19 | emerging field of nanotechnology | | | | | | | 1 | 0.27% |
20 | of nanotechnology applied to | | | | | | | 1 | 0.27% |
21 | office of science and | | | | | | | 1 | 0.27% |
22 | nanomedicine received a very | | | | | | | 1 | 0.27% |
23 | in the lancet medical | | | | | | | 1 | 0.27% |
24 | review in the lancet | | | | | | | 1 | 0.27% |
25 | favorable review in the | | | | | | | 1 | 0.27% |
26 | very favorable review in | | | | | | | 1 | 0.27% |
27 | a very favorable review | | | | | | | 1 | 0.27% |
28 | received a very favorable | | | | | | | 1 | 0.27% |
29 | the first volume of | | | | | | | 1 | 0.27% |
30 | nanotechnology applied to medicine | | | | | | | 1 | 0.27% |
31 | freitas the first volume | | | | | | | 1 | 0.27% |
32 | robert freitas the first | | | | | | | 1 | 0.27% |
33 | fellow robert freitas the | | | | | | | 1 | 0.27% |
34 | research fellow robert freitas | | | | | | | 1 | 0.27% |
35 | imm research fellow robert | | | | | | | 1 | 0.27% |
36 | by imm research fellow | | | | | | | 1 | 0.27% |
37 | nanomedicine by imm research | | | | | | | 1 | 0.27% |
38 | of science and technology | | | | | | | 1 | 0.27% |
39 | the office of science | | | | | | | 1 | 0.27% |
40 | imm participated in the | | | | | | | 1 | 0.27% |